OCLG OTC
Oncologix Tech Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -86.7%
5Y: -95.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3M
+0.0% ▲
Gross Profit
$572K
+0.0% ▲
Operating Income
-$865K
+0.0% ▲
Net Income
-$2M
+0.0% ▲
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
-$1M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $244K | $4M | $5M | $4M | $3M |
| YoY Growth | +0.0% | +1405.4% | +33.3% | -18.2% | -29.0% |
| Cost of Revenue | $196K | $3M | $4M | $3M | $2M |
| Gross Profit | $49K | $614K | $1M | $1M | $572K |
| Gross Margin | 19.9% | 16.7% | 28.0% | 30.3% | 20.1% |
| R&D Expenses | $0 | $30K | $0 | $0 | $0 |
| SG&A Expenses | $330K | $1M | $2M | $2M | $1M |
| Operating Expenses | $330K | $1M | $2M | $2M | $1M |
| Operating Income | -$287K | -$572K | -$509K | -$512K | -$865K |
| Operating Margin | -117.5% | -15.6% | -10.4% | -12.8% | -30.4% |
| Interest Expense | $186K | $809K | $2M | $698K | $1M |
| Income Before Tax | -$653K | -$1M | -$3M | -$2M | -$2M |
| Tax Expense | $0 | $0 | $3 | $0 | $3 |
| Net Income | -$653K | -$1M | -$3M | -$2M | -$2M |
| Net Margin | -267.4% | -35.7% | -52.1% | -46.1% | -83.2% |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | -$462K | -$576K | -$923K | -$1M | -$1M |
| Shares Outstanding | 62M | 103M | 316M | 720M | 737M |